Alambic Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-24,400	Closed	-$694K	–	371
2018 Q1	$694K	Buy	24,400 +7,600	+45%	+$216K	0.1%	280
2017 Q4	$355K	Buy	+16,800	New	+$355K	0.04%	359